Asset Details
Do you wish to reserve the book?
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
Do you wish to request the book?
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
2025
Overview
Adipocyte dysfunction plays a critical role in the pathogenesis of metabolic diseases, including type 2 diabetes (T2D). Human induced pluripotent stem cells (hiPSCs) offer a powerful platform for generating white, beige, and brown adipocytes, supporting both disease modeling and therapeutic research. This review provides a comprehensive summary of current differentiation methods to produce three functionally mature adipocyte types from pluripotent stem cells (PSCs), including forced gene expression techniques, developmental biology-inspired approaches, and advanced three-dimensional (3D) culture systems that enhance cellular maturity and functional relevance. PSC-derived white adipocytes contribute to modeling adipocyte dysfunction not only in conditions such as insulin resistance, lipodystrophy, and premature aging but also in more complex metabolic diseases, including T2D, facilitating the investigation of disease mechanisms and the identification of novel therapeutic targets. In addition, iPSC-based models provide a robust platform for exploring genetic regulation by genome-wide association studies (GWAS)–identified variants through population genetics. This review also evaluates the therapeutic potential of iPSC-derived white, beige, and brown adipocytes in cell transplantation therapy for metabolic diseases, with a focus on engraftment potential and metabolic improvement. Enhancing the maturity and subtype specificity of PSC-derived adipocytes is expected to accelerate the development of personalized medicine and innovative therapeutic strategies for metabolic diseases.
Graphical Abstract
Publisher
SAGE Publications,Sage Publications Ltd,SAGE Publishing
Subject
/ Adipocytes, Beige - cytology
/ Adipocytes, Beige - metabolism
/ Adipocytes, Beige - transplantation
/ Adipocytes, Brown - cytology
/ Adipocytes, Brown - metabolism
/ Adipocytes, Brown - transplantation
/ Adipocytes, White - cytology
/ Adipocytes, White - metabolism
/ Adipocytes, White - transplantation
/ Animals
/ Diabetes mellitus (non-insulin dependent)
/ Disease
/ Genome-wide association studies
/ Humans
/ Induced Pluripotent Stem Cells - cytology
/ Induced Pluripotent Stem Cells - metabolism
/ Induced Pluripotent Stem Cells - transplantation
